These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29705850)

  • 81. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
    Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A non-radioisotopic human natural killer cell assay using rhodamine-123 fluorescent dye as labelling probe.
    Iwao M; Ochi C; Kurane I; Muraoka S
    Immunol Invest; 1998; 27(1-2):31-45. PubMed ID: 9561916
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The effects of IL-17 upon human natural killer cells.
    Al Omar S; Flanagan BF; Almehmadi M; Christmas SE
    Cytokine; 2013 Apr; 62(1):123-30. PubMed ID: 23490420
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry.
    Kasatori N; Ishikawa F; Ueyama M; Urayama T
    J Immunol Methods; 2005 Dec; 307(1-2):41-53. PubMed ID: 16246359
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evaluation of human natural killer cell activities in whole blood.
    Claus M; Watzl C
    Curr Protoc Immunol; 2010 Nov; Chapter 7():Unit7.39. PubMed ID: 21053306
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of natural killer cell assay performance on shipped blood specimens.
    Querec TD; Abrams J; Stewart JJ; Barnes Z; Balbin E; Klimas N; Fletcher MA; Brown L; Bertolli J; Unger ER
    J Immunol Methods; 2021 Aug; 495():113049. PubMed ID: 33819446
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Cytotoxicity of allogenetic natural killer cells against CD34+ acute myelogenous leukemia cells].
    Niu XQ; Guo KY; Zhou J; Hu LS; Tu SF; She MR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):173-5. PubMed ID: 18250035
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Flow cytometry-based
    Wong P; Wagner JA; Berrien-Elliott MM; Schappe T; Fehniger TA
    STAR Protoc; 2021 Mar; 2(1):100262. PubMed ID: 33490978
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Flow Cytometric Analysis of Natural Killer Cell Lytic Activity in Human Whole Blood.
    McBride JE; Meaney MP; John C; Nieman DC; Warin RF
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362366
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays.
    Wallace D; Hildesheim A; Pinto LA
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):255-60. PubMed ID: 15013972
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Quantifying the stress induced by distress in patients with lumbar disc herniation in terms of natural killer cell activity measurements: chromium release assay versus multiparameter flow cytometric assay.
    Sato N; Kikuchi S; Sato K
    Spine (Phila Pa 1976); 2002 Oct; 27(19):2095-100. PubMed ID: 12394920
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Determination of Cytotoxic Activities Against Melanoma Cells Using Flow Cytometry.
    Shi G; Heller R
    Methods Mol Biol; 2021; 2265():111-118. PubMed ID: 33704709
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Real-Time Cytotoxicity Assay as an Alternative to the Standard Chromium-51 Release Assay for Measurement of Human NK and T Cell Cytotoxic Activity.
    Fassy J; Tsalkitzi K; Goncalves-Maia M; Braud VM
    Curr Protoc Immunol; 2017 Aug; 118():7.42.1-7.42.12. PubMed ID: 28762488
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood.
    Holicek P; Truxova I; Kasikova L; Vosahlikova S; Salek C; Rakova J; Holubova M; Lysak D; Cremer I; Spisek R; Fucikova J
    Methods Enzymol; 2020; 631():277-287. PubMed ID: 31948552
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Improving methods of assessing natural killer cell cytotoxicity.
    Sephton SE; Kraemer HC; Neri E; Stites DP; Weissbecker I; Spiegel D
    Int J Methods Psychiatr Res; 2006; 15(1):12-21. PubMed ID: 16676682
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Natural killer cell activity in atopic dermatitis.
    Viander M; Uksila J; Lassila O; Jansén CT
    Arch Dermatol Res; 1982; 274(3-4):283-8. PubMed ID: 6299206
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Investigation of NK cell function against two target hematological cell line using radioactive chromium assay.
    Jurišić V
    Appl Radiat Isot; 2024 Apr; 206():111251. PubMed ID: 38422944
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Absence of circulating natural killer (NK) cells in a child with erythrophagocytic lymphohistiocytosis lacking NK cell activity.
    Kawai H; Komiyama A; Aoyama K; Miyagawa Y; Akabane T
    Am J Hematol; 1988 Jun; 28(2):107-12. PubMed ID: 3293437
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A sensitive test for the detection of NK activity. Plasma clot clonogenic assay.
    Dinota A; Gobbi M; Tazzari PL; Raspadori D; Bontadini A; Lauria F; Foà R; Tura S
    J Immunol Methods; 1988 Nov; 114(1-2):53-9. PubMed ID: 3183397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.